The Russian Federal Medical and Biological Agency (FMBA) has received a certificate of permanent registration for the anti-Covid drug “Mir-19”. writes about this TASS.
In the statement, the institution stated that preclinical and clinical studies of Mir-19 showed its effectiveness and safety. At the end of 2023, experts completed the third phase of clinical trials of the drug. As a result, the Russian Ministry of Health issued a permanent registration certificate for the drug for medical use, the press service noted.
Before that, at NICEM, named after NF. Gamaleya Ministry of Health of the Russian Federation saidHe said that the center’s experts, together with the Moscow Ministry of Health, evaluated the effectiveness of the Sputnik V vaccine with its original antigenic composition throughout the entire period of the pandemic. It turned out that the drug still protected vaccinated people.
The study found that Sputnik V provided strong protection of 90% against death and more than 80% against hospitalization, although the vaccine’s level of protection against infection changed due to the emergence of new variants of the virus.
Previously virologist appreciated A dangerous side effect of Western vaccines against COVID-19.